tiprankstipranks
Trending News
More News >
Protalix Biotherapeutics (PLX)
:PLX
US Market

Protalix (PLX) Income Statement

Compare
934 Followers

Protalix Income Statement

Last quarter (Q3 2025), Protalix's total revenue was $17.85M, a decrease of -0.60% from the same quarter last year. In Q3, Protalix's net income was $2.35M. See Protalix’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 53.40M$ 65.49M$ 47.64M$ 38.35M$ 62.90M
Gross Profit
$ 29.08M$ 42.51M$ 28.05M$ 22.00M$ 52.02M
Operating Expenses
$ 25.16M$ 32.05M$ 41.06M$ 42.46M$ 49.31M
Depreciation and Amortization
$ 1.30M$ 1.19M$ 1.09M$ 1.12M$ 1.30M
EBITDA
$ 6.52M$ 12.94M$ -10.78M$ -18.94M$ 4.45M
Operating Income
$ 3.92M$ 10.46M$ -13.01M$ -20.46M$ 2.71M
Other Income/Expenses
$ 237.00K$ -1.89M$ -1.38M$ -7.12M$ -9.23M
Pretax Income
$ 4.15M$ 8.57M$ -14.40M$ -27.58M$ -6.52M
Net Income
$ 2.93M$ 8.31M$ -14.93M$ -27.58M$ -6.52M
Per Share Metrics
Basic EPS
$ 0.04$ 0.12$ -0.31$ -0.62$ -0.22
Diluted EPS
$ 0.04$ 0.10$ -0.31$ -0.62$ -0.22
Weighted Average Shares Outstanding
72.53M 67.51M 48.47M 44.14M 29.15M
Weighted Average Shares Outstanding (Diluted)
81.06M 82.42M 48.47M 44.14M 29.15M
Currency in USD

Protalix Earnings and Revenue History